The term "reactive hypoglycemia" (RH) has traditionally been used to describe a condition characterized by recurrent episodes of symptomatic hypoglycemia (<70 mg/dL) occurring within 2-4 hours after a high carbohydrate meal in otherwise healthy individuals.
Letter to the Editor
The term "reactive hypoglycemia" (RH) has traditionally been used to describe a condition characterized by recurrent episodes of symptomatic hypoglycemia (<70 mg/dL) occurring within 2-4 hours after a high carbohydrate meal in otherwise healthy individuals. 1 Although the causes and mechanisms are not well understood, it has been suggested that early RH may be the result of an exaggerated glucagon-like-peptide-1 (GLP-1) response, 2 and that greater carbohydrate loads, which lead to an increased incretin effect, may result in more severe reactive hypoglycaemia. 3 When diagnosing RH, it must be shown to be associated with the sympathetic and/or neuroglycopenic symptoms associated with biochemical hypoglycaemia. 2 Diagnosis is often based on mixed meal evaluation; however, a high percentage of symptomatic patients test negative when using this approach. 2 Use of an oral glucose tolerance test has also been shown to be insufficient to diagnose the condition. 3 Although periodic ambulatory blood glucose testing has been used to investigate this condition, this approach only provides a "snapshot" of postprandial blood glucose (BG) levels; it does not take into account the potential time lag between actual biochemical hypoglycemia and recognition of symptoms, which would prompt the individual to test his/ her BG. During this lag period, glucose may actually be rising in response to the action of counterregulatory hormones and the true nadir may be missed. 4 Use of continuous glucose monitoring (CGM) may improve diagnosis accuracy. 2 We assessed the diagnostic value of short-term CGM use in patients without diabetes with suspected RH.
This retrospective analysis included 3 patients without diabetes (1 male, 2 female) with suspected RH. Median age was 33 (range: 31-35) years; median BMI 25.2 kg/m 2 (range: 19.5-31.7) Patients were asked to wear Dexcom G4 CGM system (Dexcom, Inc, San Diego, USA) for 7 days. Data were then downloaded for analysis.
In one patient, a significant decrease in glucose was observed in response to high carbohydrate intake on two separate days ( Figure 1A ). These decreases occurred within approximately 30-40 minutes following peak postprandial glucose. Similar patterns following ingestion of high-carbohydrate meals were seen in the other study patients ( Figure 1B and 1C) . The magnitude and timing of the patterns did not appear to be associated with gender or BMI. All patients were counseled to modify their eating with a low-carbohydrate diet and frequent small split meals. These actions resolved their RH.
RH can result in debilitating symptoms similar to those experienced by patients with diabetes. 2 Although dietary modification remains the first treatment of this disorder, 2, 5, 6 individuals who do not respond to this treatment require further investigation. Utilization of CGM may provide a practical means for confirming RH in individuals without diabetes, facilitating early intervention with diet modification, assessment of treatment efficacy, and identification of individuals requiring more comprehensive evaluation.
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